Economic burden of type-2 diabetes in Peru: a cost-of-illness study valuing cost differences associated with the level of glycemic control.
Janice SeinfeldAlfredo SobrevillaMaría Laura RosalesMauricio IbáñezDelia RuizEduardo PennySergio LondoñoPublished in: Expert review of pharmacoeconomics & outcomes research (2024)
T2DM places a heavy burden on the Peruvian healthcare budget that will be even greater if poor glycemic control is maintained.